Vitamin B12 [EPC]

Vitamin B12 [EPC] was reported 325272 times

Drugs of the Vitamin B12 [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5706 0.7956
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 507 0.7590
2 PEMPHIGUS 9339 0.7462
3 SWOLLEN JOINT COUNT INCREASED 2374 0.7437
4 RHEUMATIC FEVER 3194 0.7158
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 1400 0.6990
6 DUODENAL ULCER PERFORATION 5172 0.6948
7 RHEUMATOID FACTOR POSITIVE 3903 0.6750
8 C-REACTIVE PROTEIN 602 0.6494
9 LUPUS VULGARIS 817 0.6484
10 HAND DEFORMITY 7887 0.6007
11 FACET JOINT SYNDROME 1946 0.5971
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1106 0.5333
13 HELICOBACTER INFECTION 5253 0.5106
14 DISLOCATION OF VERTEBRA 1117 0.4893
15 X-RAY ABNORMAL 806 0.4503
16 MUSCLE INJURY 3652 0.4403
17 SYNOVITIS 7912 0.4384
18 C-REACTIVE PROTEIN ABNORMAL 2802 0.4364
19 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2695 0.4146
20 GLOSSODYNIA 8891 0.3967
21 RETINITIS 681 0.3939
22 FOLLICULITIS 4117 0.3922
23 PERICARDITIS 6394 0.3802
24 PERIPHERAL VENOUS DISEASE 1510 0.3694
25 BLOOD PRESSURE SYSTOLIC ABNORMAL 867 0.3504
26 BLOOD PRESSURE DIASTOLIC ABNORMAL 867 0.3405
27 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 757 0.3283
28 SERONEGATIVE ARTHRITIS 376 0.3281
29 GRANULOMA SKIN 245 0.2984
30 BONE EROSION 1054 0.2977
31 SYSTEMIC LUPUS ERYTHEMATOSUS 10458 0.2944
32 WOUND 7865 0.2811
33 CONTRAINDICATED PRODUCT ADMINISTERED 7531 0.2485
34 ENTHESOPATHY 378 0.2415
35 JOINT DESTRUCTION 375 0.2410
36 BREAST CANCER STAGE III 1538 0.2372
37 DRUG TOLERANCE DECREASED 654 0.2327
38 JOINT RANGE OF MOTION DECREASED 3020 0.2250
39 LIP DRY 2041 0.2245
40 GRIP STRENGTH DECREASED 1975 0.2242
41 PORPHYRIA ACUTE 317 0.2209
42 RHEUMATOID NODULE 578 0.2096
43 ONYCHOMADESIS 874 0.2080
44 HYPERCHOLESTEROLAEMIA 1998 0.2067
45 BURSITIS 2479 0.2041
46 LIVE BIRTH 1699 0.2029
47 IRRITABLE BOWEL SYNDROME 4314 0.2010
48 WOUND INFECTION 2188 0.1996
49 BLOOD PARATHYROID HORMONE DECREASED 281 0.1895
50 FIBROMYALGIA 4518 0.1857
51 ONYCHOMYCOSIS 799 0.1819
52 ARTHROPATHY 10013 0.1800
53 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1916 0.1730
54 RHEUMATOID ARTHRITIS 18770 0.1652
55 IMPAIRED HEALING 5289 0.1609
56 AUTOIMMUNE DISORDER 1558 0.1597
57 TENOSYNOVITIS 438 0.1586
58 FINGER DEFORMITY 765 0.1578
59 POLYCYSTIC OVARIES 239 0.1540
60 BLEPHAROSPASM 969 0.1537
61 PSORIATIC ARTHROPATHY 6043 0.1487
62 INFUSION RELATED REACTION 9481 0.1429
63 FOOT DEFORMITY 1532 0.1381
64 LIVER INJURY 3390 0.1380
65 EXOSTOSIS 1247 0.1364
66 SCIATICA 2149 0.1347
67 OBESITY 2117 0.1327
68 HIP ARTHROPLASTY 2011 0.1312
69 NAIL DISORDER 1143 0.1305
70 PULMONARY FIBROSIS 2437 0.1269
71 MATERNAL EXPOSURE TIMING UNSPECIFIED 474 0.1261
72 TYPE 2 DIABETES MELLITUS 4246 0.1260
73 LOWER RESPIRATORY TRACT INFECTION 5677 0.1247
74 PANNICULITIS 300 0.1239
75 OSTEOARTHRITIS 5245 0.1236
76 THERAPEUTIC PRODUCT EFFECT DECREASED 5515 0.1230
77 BLOOD PRESSURE DIASTOLIC DECREASED 902 0.1221
78 DYSMORPHISM 287 0.1217
79 HEPATIC ENZYME INCREASED 7869 0.1153
80 INFUSION SITE REACTION 341 0.1140
81 DISCOMFORT 6928 0.1134
82 JOINT EFFUSION 777 0.1126
83 KNEE ARTHROPLASTY 2333 0.1107
84 WALKING AID USER 728 0.1103
85 ALANINE AMINOTRANSFERASE ABNORMAL 232 0.1099
86 SWELLING 10125 0.1081
87 BLOOD PRESSURE DIASTOLIC INCREASED 498 0.1078
88 C-REACTIVE PROTEIN INCREASED 3912 0.1074
89 BLOOD PRESSURE SYSTOLIC INCREASED 2096 0.1074
90 JOINT SWELLING 12777 0.1057
91 JOINT DISLOCATION 1116 0.1055
92 POLYARTHRITIS 549 0.1040
93 LUPUS-LIKE SYNDROME 940 0.1035
94 MATERNAL EXPOSURE DURING PREGNANCY 8942 0.1002
95 NEPHROGENIC ANAEMIA 462 0.0996
96 BLISTER 5577 0.0992
97 SPONDYLITIS 361 0.0992
98 BLOOD CHOLESTEROL INCREASED 4583 0.0982
99 PUSTULAR PSORIASIS 337 0.0980
100 LOWER LIMB FRACTURE 1815 0.0944
101 HYPERPARATHYROIDISM SECONDARY 235 0.0937
102 SYNOVIAL CYST 429 0.0928
103 STOMATITIS 5619 0.0926
104 DRUG INTOLERANCE 8899 0.0920
105 PLEURITIC PAIN 252 0.0912
106 MUSCULOSKELETAL STIFFNESS 7949 0.0906
107 PRESCRIBED OVERDOSE 1748 0.0902
108 SICKLE CELL ANAEMIA WITH CRISIS 1383 0.0877
109 BLOOD PRESSURE FLUCTUATION 2101 0.0874
110 INFLAMMATION 4490 0.0869
111 GAIT INABILITY 2897 0.0866
112 BACK INJURY 935 0.0859
113 DRUG TOLERANCE 431 0.0851
114 BODY TEMPERATURE DECREASED 831 0.0843
115 GESTATIONAL DIABETES 400 0.0839
116 RED CELL DISTRIBUTION WIDTH INCREASED 342 0.0822
117 SMALL FOR DATES BABY 406 0.0817
118 JOINT STIFFNESS 2120 0.0807
119 ULCER HAEMORRHAGE 544 0.0803
120 NIGHT SWEATS 2572 0.0797
121 RHINITIS ALLERGIC 353 0.0792
122 CONGENITAL ANOMALY 613 0.0791
123 ABDOMINAL DISCOMFORT 13227 0.0788
124 SINUSITIS 8078 0.0787
125 MOBILITY DECREASED 5652 0.0786
126 CUSHINGOID 248 0.0772
127 ARTHRITIS INFECTIVE 357 0.0769
128 MUSCULOSKELETAL PAIN 4023 0.0767
129 INTERVERTEBRAL DISC DEGENERATION 703 0.0759
130 PRESCRIBED UNDERDOSE 1505 0.0754
131 VITAMIN B12 DEFICIENCY 304 0.0750
132 WHEEZING 4443 0.0748
133 BREATH SOUNDS ABNORMAL 369 0.0748
134 SPINAL OSTEOARTHRITIS 656 0.0746
135 SPINAL STENOSIS 304 0.0736
136 TREATMENT FAILURE 6006 0.0724
137 NORMAL NEWBORN 385 0.0708
138 COELIAC DISEASE 694 0.0707
139 CARPAL TUNNEL SYNDROME 989 0.0705
140 PREGNANCY 1409 0.0703
141 BASAL CELL CARCINOMA 1097 0.0702
142 HEPATIC CIRRHOSIS 1316 0.0700
143 SERUM FERRITIN INCREASED 369 0.0699
144 PRODUCT LABEL CONFUSION 406 0.0696
145 TENDERNESS 717 0.0687
146 BRONCHIECTASIS 463 0.0687
147 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3289 0.0684
148 NODULE 892 0.0683
149 OEDEMA 3697 0.0681
150 SPINAL FUSION SURGERY 276 0.0680
151 INTENTIONAL PRODUCT USE ISSUE 5944 0.0678
152 ALOPECIA 13275 0.0675
153 CONTUSION 6504 0.0675
154 LIVER FUNCTION TEST INCREASED 1449 0.0674
155 EXPOSURE DURING PREGNANCY 4183 0.0672
156 ARTHRITIS 5280 0.0671
157 EAR INFECTION 1767 0.0663
158 IMMUNODEFICIENCY 988 0.0662
159 ILL-DEFINED DISORDER 3976 0.0654
160 BREAST CANCER STAGE II 544 0.0653
161 RASH VESICULAR 314 0.0649
162 WHEELCHAIR USER 285 0.0640
163 IRON DEFICIENCY 288 0.0640
164 ANAL FISSURE 343 0.0639
165 VENTRICULAR SEPTAL DEFECT 364 0.0635
166 CARDIAC MURMUR 550 0.0635
167 PERIPHERAL SWELLING 9731 0.0631
168 ARTHRITIS BACTERIAL 258 0.0628
169 SKIN NECROSIS 326 0.0628
170 POOR VENOUS ACCESS 647 0.0625
171 POSTOPERATIVE WOUND INFECTION 422 0.0624
172 LUNG DISORDER 3057 0.0623
173 HAEMATOCRIT DECREASED 1235 0.0622
174 GENERAL PHYSICAL HEALTH DETERIORATION 7197 0.0621
175 INFLAMMATORY MARKER INCREASED 307 0.0619
176 ATRIAL SEPTAL DEFECT 517 0.0617
177 OSTEOPOROSIS 2533 0.0615
178 PRE-ECLAMPSIA 290 0.0610
179 NASOPHARYNGITIS 11159 0.0605
180 SPINAL COLUMN STENOSIS 285 0.0603
181 PREMATURE LABOUR 337 0.0595
182 MENISCUS INJURY 366 0.0595
183 SINUS CONGESTION 798 0.0590
184 EAR PAIN 1148 0.0590
185 INJECTION SITE PAPULE 270 0.0589
186 INJURY 4147 0.0589
187 VITAMIN D DECREASED 503 0.0588
188 MATERNAL EXPOSURE BEFORE PREGNANCY 397 0.0581
189 ROAD TRAFFIC ACCIDENT 2415 0.0577
190 GASTROINTESTINAL DISORDER 5164 0.0576
191 VITAMIN D DEFICIENCY 561 0.0575
192 LOW BIRTH WEIGHT BABY 456 0.0573
193 TASTE DISORDER 1159 0.0571
194 HEART RATE DECREASED 2005 0.0570
195 ATELECTASIS 547 0.0566
196 SKIN ABRASION 267 0.0564
197 HAEMOLYSIS 435 0.0563
198 SLEEP DISORDER 3973 0.0562
199 APHTHOUS ULCER 433 0.0558
200 RHINITIS 450 0.0558
201 UPPER RESPIRATORY TRACT INFECTION 2575 0.0557
202 ARTHRALGIA 22943 0.0551
203 SLEEP APNOEA SYNDROME 1053 0.0551
204 SENSORY LOSS 443 0.0550
205 INFECTION 7828 0.0540
206 BLOOD ALBUMIN DECREASED 425 0.0535
207 FOOT OPERATION 265 0.0535
208 LOCALISED INFECTION 1291 0.0533
209 BLOOD IRON DECREASED 633 0.0533
210 TONGUE DISORDER 383 0.0529
211 RENAL CYST 420 0.0528
212 UMBILICAL HERNIA 247 0.0528
213 ROTATOR CUFF SYNDROME 678 0.0527
214 ANAL FISTULA 281 0.0526
215 LIVER DISORDER 2323 0.0523
216 HIATUS HERNIA 676 0.0522
217 SKIN ULCER 1349 0.0521
218 NECK PAIN 2900 0.0518
219 THERAPY NON-RESPONDER 2326 0.0517
220 POST PROCEDURAL INFECTION 420 0.0516
221 SQUAMOUS CELL CARCINOMA OF SKIN 310 0.0513
222 MOUTH ULCERATION 1078 0.0511
223 PRE-EXISTING CONDITION IMPROVED 318 0.0509
224 ULCER 805 0.0505
225 BRONCHITIS 3738 0.0504
226 HUMERUS FRACTURE 243 0.0503
227 FOETAL GROWTH RESTRICTION 306 0.0503
228 HYPERSENSITIVITY 9331 0.0502
229 GINGIVAL PAIN 400 0.0502
230 EPILEPSY 1535 0.0502
231 PULMONARY MASS 748 0.0502
232 SCOLIOSIS 311 0.0502
233 HYPERCALCAEMIA 618 0.0500
234 HAEMOGLOBIN DECREASED 5139 0.0500
235 INCREASED TENDENCY TO BRUISE 460 0.0499
236 DRY MOUTH 4044 0.0498
237 RESPIRATORY RATE INCREASED 442 0.0497
238 RESPIRATORY TRACT INFECTION 1295 0.0497
239 TOOTH INFECTION 655 0.0496
240 BLOOD TEST ABNORMAL 697 0.0496
241 TENDONITIS 765 0.0494
242 CAESAREAN SECTION 571 0.0490
243 GASTROOESOPHAGEAL REFLUX DISEASE 3945 0.0490
244 IRON DEFICIENCY ANAEMIA 452 0.0489
245 OSTEOPENIA 741 0.0488
246 JOINT INJURY 1043 0.0488
247 BENIGN PROSTATIC HYPERPLASIA 252 0.0488
248 FREQUENT BOWEL MOVEMENTS 1317 0.0487
249 TOOTH ABSCESS 496 0.0487
250 HEPATITIS 1246 0.0486
251 DELIRIUM 1686 0.0485
252 PHARYNGITIS 602 0.0485
253 SENSITIVITY TO WEATHER CHANGE 255 0.0484
254 BLOOD MAGNESIUM DECREASED 418 0.0484
255 NERVE COMPRESSION 446 0.0483
256 OXYGEN SATURATION DECREASED 2714 0.0482
257 SKIN LACERATION 525 0.0482
258 CONFUSIONAL STATE 7760 0.0480
259 PANCYTOPENIA 2682 0.0479
260 DIVERTICULUM 341 0.0479
261 MATERNAL DRUGS AFFECTING FOETUS 367 0.0478
262 CELLULITIS 2408 0.0477
263 CYSTITIS 1517 0.0476
264 HYPOAESTHESIA 7126 0.0476
265 GASTROENTERITIS VIRAL 859 0.0475
266 RED BLOOD CELL COUNT DECREASED 1354 0.0473
267 HYPERKERATOSIS 260 0.0471
268 RESPIRATORY TRACT CONGESTION 747 0.0470
269 CYST 583 0.0469
270 PELVIC FRACTURE 365 0.0468
271 IMMUNOSUPPRESSION 412 0.0467
272 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 800 0.0466
273 FLANK PAIN 437 0.0466
274 MUSCLE SPASTICITY 570 0.0463
275 SMALL INTESTINAL OBSTRUCTION 569 0.0462
276 HYPERTENSION 9737 0.0459
277 LIGAMENT SPRAIN 454 0.0459
278 ARTHROPOD BITE 340 0.0458
279 PLATELET COUNT INCREASED 593 0.0454
280 DISABILITY 899 0.0454
281 APLASTIC ANAEMIA 236 0.0451
282 SKIN INFECTION 506 0.0451
283 ADRENAL INSUFFICIENCY 547 0.0450
284 INGUINAL HERNIA 274 0.0450
285 WEIGHT INCREASED 10085 0.0450
286 MYOSITIS 404 0.0450
287 MOTOR DYSFUNCTION 457 0.0448
288 HEPATIC STEATOSIS 835 0.0448
289 FOETAL EXPOSURE DURING PREGNANCY 3638 0.0447
290 TRICUSPID VALVE INCOMPETENCE 355 0.0446
291 PAIN 27395 0.0446
292 OEDEMA PERIPHERAL 5433 0.0445
293 DRUG-INDUCED LIVER INJURY 1385 0.0441
294 HAND FRACTURE 312 0.0440
295 POLYP 287 0.0438
296 FOOT FRACTURE 831 0.0438
297 CONDITION AGGRAVATED 13326 0.0438
298 DYSPEPSIA 4310 0.0438
299 PAIN IN EXTREMITY 12867 0.0436
300 WEIGHT FLUCTUATION 456 0.0435
301 GASTROENTERITIS 634 0.0434
302 INTERVERTEBRAL DISC PROTRUSION 947 0.0433
303 ANKYLOSING SPONDYLITIS 570 0.0432
304 MASS 603 0.0431
305 BACK DISORDER 701 0.0431
306 SPINAL DISORDER 408 0.0430
307 GANGRENE 259 0.0429
308 HERPES ZOSTER 2460 0.0428
309 MIGRAINE 4059 0.0425
310 DRUG LEVEL BELOW THERAPEUTIC 234 0.0424
311 END STAGE RENAL DISEASE 772 0.0423
312 DIVERTICULITIS 1170 0.0422
313 SEASONAL ALLERGY 597 0.0421
314 ARTERIAL OCCLUSIVE DISEASE 331 0.0421
315 TOOTH FRACTURE 464 0.0420
316 BONE DISORDER 766 0.0420
317 PRODUCT USE ISSUE 7882 0.0419
318 ORAL CANDIDIASIS 552 0.0419
319 PNEUMONIA 13547 0.0418
320 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 709 0.0417
321 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2962 0.0416
322 HEMIPLEGIA 346 0.0416
323 SQUAMOUS CELL CARCINOMA 391 0.0415
324 SPLENOMEGALY 486 0.0414
325 NEUTROPENIC SEPSIS 296 0.0414
326 MUSCULAR WEAKNESS 4689 0.0412
327 KIDNEY INFECTION 801 0.0408
328 WHITE BLOOD CELL COUNT INCREASED 1564 0.0407
329 LOCAL SWELLING 709 0.0406
330 ARTERIOSCLEROSIS CORONARY ARTERY 269 0.0406
331 MITRAL VALVE INCOMPETENCE 459 0.0405
332 RECTAL HAEMORRHAGE 1739 0.0404
333 FISTULA 453 0.0403
334 OROPHARYNGEAL PAIN 3730 0.0403
335 PRODUCTIVE COUGH 1915 0.0401
336 PLEURISY 237 0.0399
337 URINARY TRACT INFECTION 6798 0.0398
338 FULL BLOOD COUNT ABNORMAL 421 0.0398
339 SPINAL COMPRESSION FRACTURE 329 0.0398
340 CARDIOMEGALY 487 0.0396
341 MUSCLE STRAIN 342 0.0395
342 RHINORRHOEA 2555 0.0395
343 MUSCULOSKELETAL CHEST PAIN 611 0.0394
344 PREMATURE DELIVERY 628 0.0394
345 RIB FRACTURE 811 0.0394
346 SPINAL PAIN 461 0.0393
347 TENDON DISORDER 256 0.0392
348 SPUTUM DISCOLOURED 372 0.0392
349 LACERATION 368 0.0391
350 SINUS DISORDER 772 0.0389
351 FATIGUE 30343 0.0389
352 MALIGNANT MELANOMA 522 0.0389
353 GROIN PAIN 341 0.0388
354 DENTAL CARIES 429 0.0387
355 PHARYNGITIS STREPTOCOCCAL 419 0.0387
356 GAIT DISTURBANCE 7409 0.0387
357 MUSCULOSKELETAL DISCOMFORT 665 0.0386
358 ORAL HERPES 753 0.0385
359 UVEITIS 523 0.0385
360 UPPER-AIRWAY COUGH SYNDROME 317 0.0384
361 PAROSMIA 290 0.0384
362 LIMB INJURY 1043 0.0384
363 WRIST FRACTURE 460 0.0383
364 VASCULITIS 447 0.0383
365 HEART RATE IRREGULAR 867 0.0383
366 DECUBITUS ULCER 312 0.0382
367 TRANSFUSION 401 0.0382
368 BREAST MASS 257 0.0382
369 GASTROINTESTINAL INFECTION 343 0.0382
370 PYREXIA 13240 0.0382
371 BLOOD PRESSURE INCREASED 5842 0.0382
372 EMPHYSEMA 385 0.0381
373 OVARIAN CYST 381 0.0381
374 CATARACT 2269 0.0381
375 HAEMOGLOBIN ABNORMAL 245 0.0380
376 OSTEOMYELITIS 689 0.0380
377 RASH 16470 0.0377
378 GASTRITIS 994 0.0377
379 UROSEPSIS 348 0.0377
380 FEMUR FRACTURE 1166 0.0376
381 DYSPNOEA EXERTIONAL 1418 0.0376
382 BODY HEIGHT DECREASED 402 0.0376
383 TOOTHACHE 680 0.0375
384 CHEST PAIN 6926 0.0374
385 TOOTH DISORDER 830 0.0373
386 ASTHMA 4214 0.0372
387 WEIGHT DECREASED 10403 0.0372
388 VIRAL INFECTION 1239 0.0372
389 ANAEMIA 7101 0.0372
390 BLOOD POTASSIUM DECREASED 1117 0.0371
391 NASAL CONGESTION 2179 0.0370
392 FAECES SOFT 269 0.0370
393 FALL 12262 0.0368
394 BLOOD URINE PRESENT 697 0.0367
395 ESCHERICHIA INFECTION 302 0.0367
396 LARGE INTESTINE POLYP 254 0.0366
397 ABORTION SPONTANEOUS 1467 0.0366
398 UTERINE LEIOMYOMA 267 0.0365
399 APPETITE DISORDER 242 0.0365
400 TENDON RUPTURE 450 0.0364
401 RENAL FAILURE CHRONIC 280 0.0364
402 HAEMORRHOIDS 709 0.0363
403 INFLUENZA 4045 0.0362
404 AFFECT LABILITY 349 0.0362
405 PREMATURE BABY 1089 0.0361
406 ANKLE FRACTURE 560 0.0361
407 CHOLELITHIASIS 1186 0.0361
408 DRUG EXPOSURE DURING PREGNANCY 1229 0.0361
409 LOWER GASTROINTESTINAL HAEMORRHAGE 267 0.0361
410 AMNESIA 2348 0.0361
411 NEPHROLITHIASIS 1650 0.0359
412 CORONARY ARTERY OCCLUSION 493 0.0359
413 BODY TEMPERATURE INCREASED 733 0.0359
414 HYPERLIPIDAEMIA 429 0.0359
415 CROHN'S DISEASE 246 0.0359
416 EYE INFECTION 403 0.0357
417 ABSCESS 569 0.0356
418 LUNG INFILTRATION 315 0.0356
419 INJECTION SITE HAEMATOMA 517 0.0356
420 GASTRIC ULCER 677 0.0356
421 GOUT 637 0.0355
422 RASH PRURITIC 1924 0.0355
423 GASTROINTESTINAL INFLAMMATION 278 0.0355
424 FURUNCLE 281 0.0354
425 ABDOMINAL PAIN 8195 0.0352
426 HEMIPARESIS 596 0.0351
427 MALNUTRITION 391 0.0349
428 ABDOMINAL PAIN UPPER 7184 0.0349
429 COORDINATION ABNORMAL 486 0.0348
430 CLOSTRIDIUM DIFFICILE INFECTION 756 0.0346
431 PYELONEPHRITIS 299 0.0345
432 HAEMATOCHEZIA 1904 0.0345
433 URINE OUTPUT DECREASED 301 0.0344
434 DECREASED APPETITE 7991 0.0344
435 OESOPHAGITIS 374 0.0342
436 PSORIASIS 4457 0.0341
437 HYPERAESTHESIA 280 0.0341
438 HYPOKALAEMIA 1564 0.0339
439 APHONIA 472 0.0338
440 BACK PAIN 7854 0.0338
441 HERNIA 653 0.0337
442 BLOOD UREA INCREASED 565 0.0337
443 NEURALGIA 820 0.0337
444 BLOOD CALCIUM DECREASED 379 0.0337
445 EATING DISORDER 717 0.0336
446 PLEURAL EFFUSION 2048 0.0336
447 PARAESTHESIA 5291 0.0336
448 ORAL PAIN 753 0.0336
449 UPPER LIMB FRACTURE 669 0.0335
450 HYDRONEPHROSIS 251 0.0335
451 MUSCULOSKELETAL DISORDER 637 0.0334
452 PNEUMONIA ASPIRATION 836 0.0334
453 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1741 0.0333
454 CONCUSSION 258 0.0333
455 LIVER FUNCTION TEST ABNORMAL 969 0.0333
456 HYPOTHYROIDISM 1064 0.0333
457 ACUTE RESPIRATORY FAILURE 638 0.0331
458 RESPIRATORY DISORDER 992 0.0331
459 ASTHENIA 12468 0.0331
460 COUGH 9254 0.0330
461 ATRIAL FLUTTER 263 0.0329
462 BLOOD CALCIUM INCREASED 289 0.0329
463 UPPER GASTROINTESTINAL HAEMORRHAGE 554 0.0329
464 HYSTERECTOMY 285 0.0329
465 HEPATOMEGALY 323 0.0328
466 PHOTOPHOBIA 618 0.0328
467 BLOOD LACTATE DEHYDROGENASE INCREASED 520 0.0328
468 BLOOD SODIUM DECREASED 618 0.0328
469 STAPHYLOCOCCAL INFECTION 1079 0.0327
470 ANAL INCONTINENCE 294 0.0327
471 MUCOSAL INFLAMMATION 854 0.0326
472 CLOSTRIDIUM DIFFICILE COLITIS 345 0.0325
473 DYSSTASIA 950 0.0325
474 ARTERIOSCLEROSIS 306 0.0325
475 INJECTION SITE EXTRAVASATION 401 0.0325
476 IMMUNE SYSTEM DISORDER 428 0.0324
477 SNEEZING 727 0.0324
478 GLAUCOMA 622 0.0323
479 ADVERSE REACTION 428 0.0322
480 INJECTION SITE REACTION 2219 0.0322
481 INJECTION SITE PRURITUS 2158 0.0322
482 NOCTURIA 391 0.0322
483 AORTIC ANEURYSM 245 0.0322
484 LIMB DISCOMFORT 996 0.0322
485 INJECTION SITE WARMTH 661 0.0321
486 NEPHROPATHY 300 0.0321
487 NEUTROPHIL COUNT INCREASED 329 0.0321
488 MEMORY IMPAIRMENT 4411 0.0321
489 URTICARIA 5338 0.0318
490 SUPRAVENTRICULAR TACHYCARDIA 305 0.0318
491 SECRETION DISCHARGE 398 0.0317
492 TUBULOINTERSTITIAL NEPHRITIS 595 0.0317
493 PETECHIAE 331 0.0317
494 MICTURITION URGENCY 362 0.0317
495 COLITIS ULCERATIVE 1416 0.0316
496 CHROMATURIA 713 0.0316
497 LYMPHADENOPATHY 1118 0.0316
498 SEPTIC SHOCK 1373 0.0315
499 SKIN LESION 864 0.0315
500 MEDICATION ERROR 1743 0.0313
501 BACTERIAL INFECTION 584 0.0313
502 EAR DISCOMFORT 321 0.0312
503 DRUG ERUPTION 554 0.0312
504 PULMONARY HYPERTENSION 650 0.0312
505 FULL BLOOD COUNT DECREASED 628 0.0311
506 LABORATORY TEST ABNORMAL 919 0.0311
507 ALANINE AMINOTRANSFERASE INCREASED 1910 0.0311
508 CANDIDA INFECTION 525 0.0311
509 INJECTION SITE IRRITATION 395 0.0310
510 MUSCLE SPASMS 5692 0.0310
511 DYSPNOEA 17542 0.0310
512 LYMPHOCYTE COUNT DECREASED 546 0.0309
513 TROPONIN INCREASED 235 0.0309
514 IMPAIRED WORK ABILITY 660 0.0308
515 DRUG LEVEL DECREASED 314 0.0308
516 DEHYDRATION 4100 0.0307
517 GALLBLADDER DISORDER 548 0.0307
518 HEADACHE 19232 0.0306
519 SCAB 349 0.0306
520 CHRONIC KIDNEY DISEASE 2320 0.0305
521 DIZZINESS POSTURAL 296 0.0305
522 DEPRESSION 6939 0.0305
523 FUNGAL INFECTION 1016 0.0305
524 IMPAIRED QUALITY OF LIFE 438 0.0304
525 SEPSIS 3396 0.0304
526 POST PROCEDURAL COMPLICATION 582 0.0303
527 INFUSION SITE PAIN 390 0.0302
528 ABDOMINAL DISTENSION 3157 0.0302
529 BLOOD COUNT ABNORMAL 458 0.0302
530 OBSTRUCTIVE AIRWAYS DISORDER 336 0.0302
531 ATRIAL FIBRILLATION 2934 0.0301
532 TRANSIENT ISCHAEMIC ATTACK 1015 0.0301
533 VOMITING 14128 0.0300
534 HAEMOLYTIC ANAEMIA 269 0.0300
535 HYPOMAGNESAEMIA 418 0.0300
536 ELECTROCARDIOGRAM ABNORMAL 235 0.0299
537 FLUID RETENTION 1521 0.0299
538 ASPARTATE AMINOTRANSFERASE INCREASED 1587 0.0298
539 PRODUCT ADMINISTRATION INTERRUPTED 234 0.0298
540 BLOOD CREATININE INCREASED 1944 0.0297
541 CONJUNCTIVITIS 552 0.0297
542 DIARRHOEA 19206 0.0297
543 DEFORMITY 278 0.0297
544 COVID-19 PNEUMONIA 351 0.0297
545 SKIN CANCER 640 0.0297
546 FEELING HOT 1819 0.0296
547 INSOMNIA 7866 0.0295
548 COLITIS 1119 0.0295
549 SKIN HAEMORRHAGE 437 0.0295
550 INCONTINENCE 311 0.0294
551 DIARRHOEA HAEMORRHAGIC 275 0.0294
552 PERICARDIAL EFFUSION 679 0.0293
553 BLOOD POTASSIUM INCREASED 475 0.0292
554 MYELODYSPLASTIC SYNDROME 423 0.0292
555 PNEUMONITIS 796 0.0292
556 ACUTE KIDNEY INJURY 4471 0.0292
557 ELECTROLYTE IMBALANCE 339 0.0291
558 LUNG INFECTION 452 0.0291
559 PERIPHERAL COLDNESS 398 0.0290
560 DYSURIA 1064 0.0289
561 HEPATIC CYTOLYSIS 368 0.0288
562 THERAPEUTIC RESPONSE DECREASED 1749 0.0288
563 INFUSION SITE ERYTHEMA 243 0.0288
564 RESTLESS LEGS SYNDROME 523 0.0287
565 THROAT IRRITATION 1290 0.0287
566 HYPOPHAGIA 735 0.0287
567 DYSARTHRIA 1082 0.0287
568 MALAISE 12582 0.0287
569 PLATELET COUNT DECREASED 3057 0.0287
570 APHASIA 866 0.0286
571 MACULAR DEGENERATION 342 0.0286
572 BALANCE DISORDER 2475 0.0286
573 RENAL TUBULAR NECROSIS 280 0.0285
574 ANGINA PECTORIS 817 0.0285
575 DRY THROAT 289 0.0284
576 INTERNATIONAL NORMALISED RATIO INCREASED 810 0.0284
577 HYPOCALCAEMIA 537 0.0283
578 KNEE OPERATION 278 0.0282
579 INITIAL INSOMNIA 289 0.0281
580 TOOTH EXTRACTION 350 0.0281
581 FRACTURE 532 0.0281
582 INTESTINAL OBSTRUCTION 1057 0.0280
583 HYPERSOMNIA 800 0.0279
584 PNEUMONIA BACTERIAL 256 0.0279
585 BACTERAEMIA 331 0.0279
586 PRESYNCOPE 678 0.0279
587 MOVEMENT DISORDER 894 0.0278
588 HIP FRACTURE 895 0.0278
589 HEART RATE INCREASED 2757 0.0278
590 EPISTAXIS 2080 0.0278
591 PULMONARY CONGESTION 366 0.0277
592 DIZZINESS 13844 0.0277
593 URINARY INCONTINENCE 822 0.0277
594 ASPIRATION 303 0.0276
595 CHOLECYSTECTOMY 316 0.0276
596 INJECTION SITE NODULE 304 0.0276
597 INJECTION SITE DISCOLOURATION 345 0.0276
598 INJECTION SITE BRUISING 2201 0.0276
599 NERVE INJURY 306 0.0275
600 SPINAL FRACTURE 551 0.0275
601 POOR QUALITY SLEEP 592 0.0275
602 BLADDER DISORDER 273 0.0275
603 FAECES DISCOLOURED 596 0.0275
604 PALLOR 748 0.0275
605 DEEP VEIN THROMBOSIS 1785 0.0274
606 SKIN DISCOLOURATION 1258 0.0273
607 RENAL DISORDER 1273 0.0273
608 FEELING COLD 760 0.0273
609 HYPOKINESIA 396 0.0273
610 CORONARY ARTERY DISEASE 825 0.0272
611 NAUSEA 21560 0.0272
612 HOSPICE CARE 269 0.0272
613 PHOTOSENSITIVITY REACTION 449 0.0272
614 THROMBOCYTOPENIA 3039 0.0271
615 HAEMATURIA 929 0.0271
616 DERMATITIS ALLERGIC 341 0.0271
617 PRURITUS 10416 0.0271
618 INJECTION SITE ERYTHEMA 3360 0.0271
619 RENAL FAILURE ACUTE 1148 0.0270
620 POLLAKIURIA 1123 0.0269
621 ADVERSE DRUG REACTION 2418 0.0269
622 PNEUMOCYSTIS JIROVECII PNEUMONIA 270 0.0269
623 FACIAL PAIN 240 0.0269
624 SPINAL OPERATION 331 0.0268
625 CHILLS 3148 0.0268
626 SCRATCH 283 0.0268
627 ATAXIA 318 0.0268
628 RASH PAPULAR 600 0.0267
629 HYPOTENSION 5370 0.0267
630 WHITE BLOOD CELL COUNT DECREASED 2901 0.0267
631 BLOOD PRESSURE ABNORMAL 532 0.0267
632 ADVERSE EVENT 2462 0.0267
633 DECREASED IMMUNE RESPONSIVENESS 262 0.0267
634 PULMONARY EMBOLISM 2536 0.0267
635 HEAD INJURY 844 0.0266
636 PAIN IN JAW 754 0.0266
637 CHEST DISCOMFORT 2725 0.0266
638 BURNING SENSATION 1866 0.0266
639 CHOLECYSTITIS 317 0.0266
640 HYPOXIA 936 0.0266
641 THYROID DISORDER 409 0.0265
642 HYPERKALAEMIA 928 0.0264
643 GINGIVAL BLEEDING 361 0.0264
644 LEUKOCYTOSIS 477 0.0263
645 PULMONARY THROMBOSIS 285 0.0261
646 SCAR 446 0.0260
647 TINNITUS 1193 0.0259
648 DRY EYE 1295 0.0259
649 GENERALISED OEDEMA 321 0.0259
650 HEAD DISCOMFORT 459 0.0259
651 GASTROINTESTINAL HAEMORRHAGE 2161 0.0258
652 DYSPHONIA 1511 0.0258
653 LEUKOPENIA 1291 0.0258
654 PULMONARY OEDEMA 1155 0.0258
655 FLATULENCE 1461 0.0257
656 INTESTINAL PERFORATION 289 0.0257
657 HYPONATRAEMIA 1450 0.0257
658 ORTHOSTATIC HYPOTENSION 448 0.0257
659 VITREOUS FLOATERS 252 0.0256
660 BLOOD ALKALINE PHOSPHATASE INCREASED 635 0.0255
661 INTERSTITIAL LUNG DISEASE 1229 0.0254
662 GASTROINTESTINAL PAIN 279 0.0253
663 INJECTION SITE RASH 778 0.0253
664 SKIN DISORDER 843 0.0252
665 ABASIA 624 0.0252
666 SWOLLEN TONGUE 787 0.0252
667 RASH MACULAR 880 0.0251
668 DYSPHAGIA 2381 0.0251
669 DEVICE RELATED INFECTION 386 0.0251
670 BEDRIDDEN 329 0.0250
671 INJECTION SITE PAIN 7672 0.0250
672 MENTAL STATUS CHANGES 694 0.0250
673 CARDIAC FAILURE CONGESTIVE 2005 0.0249
674 ACTIVITIES OF DAILY LIVING IMPAIRED 494 0.0249
675 EYE INFLAMMATION 238 0.0249
676 MUSCLE ATROPHY 316 0.0249
677 URINARY RETENTION 831 0.0249
678 VENTRICULAR EXTRASYSTOLES 257 0.0247
679 SINUS TACHYCARDIA 351 0.0247
680 INJECTION SITE INDURATION 320 0.0247
681 BONE MARROW FAILURE 500 0.0246
682 INTERNAL HAEMORRHAGE 281 0.0246
683 INJECTION SITE HAEMORRHAGE 1963 0.0246
684 INJECTION SITE URTICARIA 603 0.0246
685 HAEMATOMA 636 0.0245
686 RENAL FAILURE 3256 0.0245
687 THROMBOSIS 1971 0.0245
688 WRONG TECHNIQUE IN DRUG USAGE PROCESS 889 0.0244
689 INFLUENZA LIKE ILLNESS 2012 0.0244
690 EYE DISORDER 801 0.0243
691 NEUROPATHY PERIPHERAL 2310 0.0243
692 OFF LABEL USE 21265 0.0243
693 CONSTIPATION 5292 0.0242
694 BLOOD PRESSURE DECREASED 1611 0.0242
695 ANXIETY 6888 0.0242
696 FLUID OVERLOAD 352 0.0242
697 INJECTION SITE SWELLING 1853 0.0242
698 MELAENA 532 0.0241
699 PROCEDURAL PAIN 670 0.0241
700 SARS-COV-2 TEST POSITIVE 318 0.0241
701 QUALITY OF LIFE DECREASED 323 0.0241
702 COAGULOPATHY 400 0.0240
703 HAEMATEMESIS 608 0.0240
704 SWELLING FACE 1560 0.0239
705 ACUTE MYOCARDIAL INFARCTION 706 0.0239
706 THERAPY CESSATION 1228 0.0239
707 MYOCARDIAL ISCHAEMIA 272 0.0239
708 BLOOD BILIRUBIN INCREASED 645 0.0239
709 VERTIGO 1453 0.0238
710 FEBRILE NEUTROPENIA 1581 0.0238
711 BLOOD TRIGLYCERIDES INCREASED 421 0.0238
712 GASTRIC DISORDER 814 0.0237
713 TACHYCARDIA 2105 0.0237
714 LYMPHOMA 366 0.0237
715 HAEMOPTYSIS 660 0.0236
716 BREAST PAIN 252 0.0236
717 RETCHING 502 0.0235
718 DERMATITIS CONTACT 268 0.0235
719 LETHARGY 1351 0.0235
720 TRANSAMINASES INCREASED 520 0.0234
721 ABDOMINAL PAIN LOWER 589 0.0233
722 PARAESTHESIA ORAL 336 0.0233
723 HYPOAESTHESIA ORAL 351 0.0233
724 ANOREXIA 300 0.0233
725 PALPITATIONS 2724 0.0232
726 INTENTIONAL DOSE OMISSION 663 0.0232
727 BONE PAIN 1361 0.0232
728 PANCREATITIS 1228 0.0232
729 PNEUMOTHORAX 368 0.0232
730 RENAL PAIN 245 0.0231
731 DRUG EFFECT DECREASED 1243 0.0231
732 TEMPERATURE INTOLERANCE 238 0.0230
733 GLOMERULAR FILTRATION RATE DECREASED 283 0.0230
734 MUSCLE TIGHTNESS 373 0.0230
735 DRUG EFFECT INCOMPLETE 833 0.0229
736 FEEDING DISORDER 464 0.0229
737 ASCITES 672 0.0228
738 EYE HAEMORRHAGE 305 0.0228
739 DRUG INEFFECTIVE 30013 0.0227
740 PRURITUS GENERALISED 492 0.0227
741 ERYTHEMA 4673 0.0227
742 SYNCOPE 2273 0.0227
743 VISUAL IMPAIRMENT 2811 0.0227
744 RASH MACULO-PAPULAR 499 0.0224
745 MULTIPLE FRACTURES 368 0.0224
746 RASH GENERALISED 580 0.0224
747 MIDDLE INSOMNIA 418 0.0224
748 HYPERTENSIVE CRISIS 249 0.0224
749 NEUTROPHIL COUNT DECREASED 911 0.0223
750 DECREASED ACTIVITY 241 0.0223
751 SURGERY 1309 0.0223
752 DEAFNESS 583 0.0223
753 COVID-19 3898 0.0222
754 SENSORY DISTURBANCE 356 0.0222
755 INSURANCE ISSUE 339 0.0221
756 FLUSHING 2252 0.0221
757 RESPIRATORY FAILURE 1614 0.0221
758 HOT FLUSH 1660 0.0220
759 TOXIC EPIDERMAL NECROLYSIS 333 0.0219
760 IMPAIRED GASTRIC EMPTYING 298 0.0218
761 DIABETES MELLITUS INADEQUATE CONTROL 386 0.0218
762 FEELING JITTERY 414 0.0217
763 DEPRESSED MOOD 1146 0.0217
764 DIABETES MELLITUS 1651 0.0216
765 RASH ERYTHEMATOUS 1034 0.0216
766 EOSINOPHILIA 379 0.0216
767 MYALGIA 3670 0.0216
768 DIPLOPIA 560 0.0215
769 MULTI-ORGAN FAILURE 372 0.0215
770 SUBDURAL HAEMATOMA 306 0.0214
771 DEMENTIA 594 0.0212
772 ORAL DISCOMFORT 295 0.0212
773 JAUNDICE 571 0.0212
774 LOSS OF CONSCIOUSNESS 2718 0.0212
775 COGNITIVE DISORDER 990 0.0212
776 SKIN FISSURES 414 0.0212
777 THIRST 377 0.0211
778 PRODUCT DOSE OMISSION 1372 0.0210
779 DERMATITIS 439 0.0209
780 SOMNOLENCE 4217 0.0209
781 RENAL IMPAIRMENT 1750 0.0208
782 LACRIMATION INCREASED 629 0.0208
783 LYMPHOPENIA 293 0.0207
784 TREMOR 3428 0.0206
785 CARDIOMYOPATHY 305 0.0206
786 ECONOMIC PROBLEM 312 0.0206
787 HYPERTHYROIDISM 298 0.0206
788 NEUTROPENIA 2797 0.0206
789 RESPIRATORY DISTRESS 561 0.0203
790 UNEVALUABLE EVENT 1536 0.0203
791 POLYNEUROPATHY 243 0.0203
792 ERUCTATION 392 0.0202
793 DISORIENTATION 802 0.0202
794 AGEUSIA 503 0.0201
795 UNDERDOSE 1471 0.0201
796 PELVIC PAIN 366 0.0201
797 COLD SWEAT 355 0.0201
798 ENCEPHALOPATHY 494 0.0201
799 SPEECH DISORDER 1053 0.0201
800 AGRANULOCYTOSIS 373 0.0200
801 HYPERHIDROSIS 2585 0.0200
802 PRODUCT USE IN UNAPPROVED INDICATION 4969 0.0200
803 TREATMENT NONCOMPLIANCE 1093 0.0200
804 ILEUS 245 0.0197
805 HALLUCINATION, VISUAL 416 0.0197
806 ILLNESS 2029 0.0197
807 EYE PAIN 1108 0.0196
808 FEELING ABNORMAL 4692 0.0196
809 GENERALISED TONIC-CLONIC SEIZURE 324 0.0196
810 DYSGEUSIA 1452 0.0195
811 PANCREATITIS ACUTE 439 0.0195
812 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3516 0.0195
813 EJECTION FRACTION DECREASED 303 0.0195
814 DELUSION 302 0.0194
815 CARDIAC DISORDER 1813 0.0194
816 THROAT TIGHTNESS 524 0.0194
817 LIP SWELLING 645 0.0193
818 HALLUCINATION 1458 0.0193
819 THERAPEUTIC RESPONSE SHORTENED 640 0.0193
820 BLINDNESS UNILATERAL 271 0.0192
821 PERITONITIS 396 0.0191
822 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1360 0.0191
823 NERVOUSNESS 993 0.0190
824 APATHY 275 0.0188
825 DISTURBANCE IN ATTENTION 1016 0.0188
826 NIGHTMARE 649 0.0187
827 UNRESPONSIVE TO STIMULI 482 0.0187
828 VAGINAL HAEMORRHAGE 810 0.0186
829 CEREBROVASCULAR ACCIDENT 3155 0.0186
830 DRUG DOSE OMISSION 3072 0.0186
831 SKIN REACTION 261 0.0185
832 CENTRAL NERVOUS SYSTEM LESION 251 0.0182
833 LUNG NEOPLASM MALIGNANT 748 0.0182
834 CARDIOGENIC SHOCK 261 0.0182
835 THERAPEUTIC RESPONSE UNEXPECTED 815 0.0181
836 GAMMA-GLUTAMYLTRANSFERASE INCREASED 402 0.0181
837 PULMONARY ARTERIAL HYPERTENSION 262 0.0181
838 DRUG INTERACTION 2863 0.0180
839 ACUTE RESPIRATORY DISTRESS SYNDROME 319 0.0180
840 MENTAL IMPAIRMENT 437 0.0180
841 EYE SWELLING 668 0.0179
842 PHARYNGEAL OEDEMA 276 0.0179
843 COLON CANCER 267 0.0179
844 SKIN EXFOLIATION 1511 0.0179
845 HEPATOTOXICITY 398 0.0179
846 ISCHAEMIC STROKE 319 0.0179
847 VISION BLURRED 2447 0.0178
848 MENORRHAGIA 349 0.0178
849 SEIZURE 2052 0.0177
850 METABOLIC ACIDOSIS 567 0.0177
851 RENAL INJURY 526 0.0177
852 CYANOSIS 277 0.0176
853 PANIC ATTACK 640 0.0175
854 DYSKINESIA 713 0.0175
855 ARRHYTHMIA 829 0.0175
856 DEVICE MALFUNCTION 1229 0.0175
857 HYPOGLYCAEMIA 847 0.0174
858 EMOTIONAL DISORDER 538 0.0174
859 HAEMORRHAGE 1819 0.0174
860 BRADYCARDIA 921 0.0173
861 ECZEMA 908 0.0173
862 CIRCULATORY COLLAPSE 295 0.0173
863 THERAPY INTERRUPTED 1237 0.0173
864 PAIN OF SKIN 466 0.0173
865 INCREASED APPETITE 328 0.0171
866 DIALYSIS 243 0.0171
867 CARDIAC FAILURE 1373 0.0171
868 MOOD SWINGS 545 0.0171
869 CRYING 621 0.0171
870 ANAPHYLACTIC REACTION 940 0.0170
871 CONVULSION 970 0.0169
872 CARDIO-RESPIRATORY ARREST 706 0.0169
873 PLASMA CELL MYELOMA 644 0.0165
874 MUSCLE TWITCHING 380 0.0165
875 CHOLESTASIS 315 0.0164
876 HYPOACUSIS 705 0.0164
877 CHOKING 319 0.0163
878 DRUG LEVEL INCREASED 270 0.0163
879 ANHEDONIA 428 0.0163
880 RESTLESSNESS 595 0.0162
881 PRODUCT PRESCRIBING ERROR 387 0.0162
882 BRAIN FOG 254 0.0162
883 VENTRICULAR TACHYCARDIA 267 0.0162
884 ACUTE MYELOID LEUKAEMIA 252 0.0162
885 HOSPITALISATION 2480 0.0161
886 INJECTION SITE MASS 596 0.0161
887 HYPERGLYCAEMIA 585 0.0160
888 OCULAR HYPERAEMIA 756 0.0159
889 PROTEINURIA 297 0.0156
890 MYOCARDIAL INFARCTION 2711 0.0155
891 METASTASES TO BONE 255 0.0155
892 HALLUCINATION, AUDITORY 246 0.0155
893 INCORRECT DOSE ADMINISTERED 3511 0.0154
894 PRODUCT SUBSTITUTION ISSUE 883 0.0153
895 BLOOD CREATINE PHOSPHOKINASE INCREASED 439 0.0152
896 BONE DENSITY DECREASED 476 0.0152
897 MULTIPLE ORGAN DYSFUNCTION SYNDROME 429 0.0151
898 ACCIDENTAL OVERDOSE 553 0.0151
899 VISUAL ACUITY REDUCED 502 0.0151
900 CEREBRAL HAEMORRHAGE 540 0.0151
901 METASTASES TO LIVER 265 0.0151
902 THINKING ABNORMAL 280 0.0150
903 DRY SKIN 2005 0.0150
904 INTENTIONAL PRODUCT MISUSE 1314 0.0150
905 FEAR 402 0.0149
906 ABNORMAL DREAMS 411 0.0149
907 DEVICE ISSUE 1330 0.0148
908 COMA 703 0.0147
909 PRODUCT AVAILABILITY ISSUE 336 0.0147
910 OSTEONECROSIS OF JAW 365 0.0147
911 CEREBRAL INFARCTION 359 0.0147
912 MOOD ALTERED 399 0.0146
913 PRODUCT DOSE OMISSION ISSUE 4296 0.0146
914 FACE OEDEMA 245 0.0145
915 PRODUCT DOSE OMISSION IN ERROR 411 0.0145
916 ACNE 1100 0.0145
917 CARDIOVASCULAR DISORDER 364 0.0143
918 CARDIAC ARREST 1169 0.0141
919 MENTAL DISORDER 615 0.0141
920 EYE PRURITUS 473 0.0141
921 AGITATION 1031 0.0140
922 PARANOIA 241 0.0140
923 DISEASE PROGRESSION 1645 0.0139
924 MULTIPLE SCLEROSIS 664 0.0139
925 BLINDNESS 565 0.0139
926 ANGER 467 0.0138
927 NERVOUS SYSTEM DISORDER 426 0.0136
928 NEEDLE ISSUE 396 0.0136
929 TOOTH LOSS 280 0.0135
930 BLOOD GLUCOSE DECREASED 645 0.0134
931 SUICIDAL IDEATION 1220 0.0133
932 IRRITABILITY 798 0.0133
933 PRODUCT QUALITY ISSUE 1792 0.0132
934 STEVENS-JOHNSON SYNDROME 292 0.0131
935 NEOPLASM MALIGNANT 875 0.0131
936 MULTIPLE SCLEROSIS RELAPSE 890 0.0130
937 PSYCHOTIC DISORDER 383 0.0130
938 MALIGNANT NEOPLASM PROGRESSION 1323 0.0129
939 PRODUCT ADMINISTRATION ERROR 256 0.0127
940 BLOOD GLUCOSE INCREASED 2385 0.0126
941 CYTOKINE RELEASE SYNDROME 252 0.0125
942 OSTEONECROSIS 412 0.0125
943 ERECTILE DYSFUNCTION 321 0.0125
944 RHABDOMYOLYSIS 516 0.0124
945 EYE IRRITATION 707 0.0123
946 HEPATIC FAILURE 370 0.0123
947 AGGRESSION 614 0.0123
948 DEPRESSED LEVEL OF CONSCIOUSNESS 482 0.0122
949 ELECTROCARDIOGRAM QT PROLONGED 434 0.0121
950 ABNORMAL BEHAVIOUR 474 0.0120
951 DISEASE RECURRENCE 557 0.0117
952 DEVICE DISLOCATION 507 0.0116
953 INCORRECT PRODUCT ADMINISTRATION DURATION 249 0.0115
954 SKIN IRRITATION 504 0.0110
955 SHOCK 252 0.0109
956 NEOPLASM PROGRESSION 378 0.0109
957 ANGIOEDEMA 471 0.0106
958 HEPATIC FUNCTION ABNORMAL 394 0.0105
959 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 577 0.0105
960 INCORRECT DRUG ADMINISTRATION DURATION 290 0.0103
961 ANAPHYLACTIC SHOCK 261 0.0101
962 SEDATION 262 0.0100
963 DRUG ADMINISTRATION ERROR 305 0.0099
964 LACTIC ACIDOSIS 319 0.0098
965 GLYCOSYLATED HAEMOGLOBIN INCREASED 242 0.0096
966 RESPIRATORY ARREST 264 0.0096
967 MENSTRUATION IRREGULAR 253 0.0094
968 DEATH 8127 0.0094
969 PHARMACEUTICAL PRODUCT COMPLAINT 244 0.0094
970 SKIN BURNING SENSATION 660 0.0092
971 BREAST CANCER 824 0.0088
972 OVERDOSE 1897 0.0088
973 TOXICITY TO VARIOUS AGENTS 1472 0.0087
974 WITHDRAWAL SYNDROME 365 0.0087
975 EMOTIONAL DISTRESS 943 0.0078
976 EXPIRED PRODUCT ADMINISTERED 247 0.0074
977 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1460 0.0072
978 MYELOSUPPRESSION 255 0.0071
979 PROSTATE CANCER 516 0.0064
980 SUICIDE ATTEMPT 377 0.0062
981 DEVICE LEAKAGE 269 0.0062
982 EXTRA DOSE ADMINISTERED 232 0.0057
983 DERMATITIS ATOPIC 291 0.0055
984 ACCIDENTAL EXPOSURE TO PRODUCT 554 0.0054
985 PRODUCT STORAGE ERROR 403 0.0046
986 NO ADVERSE EVENT 814 0.0045
987 DRUG WITHDRAWAL SYNDROME 350 0.0040
988 INTENTIONAL OVERDOSE 246 0.0038
989 DRUG ABUSE 275 0.0033
990 COMPLETED SUICIDE 259 0.0031
991 DRUG DEPENDENCE 326 0.0020